Protalix Biotherapeutics Inc (PLX) — Cash Flow Quality Index
Protalix Biotherapeutics Inc (PLX) has a Cash Flow Quality Index of 1.85x as of December 2025. Operating cash flow of $2.03 Million exceeds net income of $1.10 Million, indicating high earnings quality where cash backs reported profits. Explore Protalix Biotherapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Protalix Biotherapeutics Inc Cash Flow Quality Index (1996–2024)
Historical Cash Flow Quality Index for Protalix Biotherapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Protalix Biotherapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Protalix Biotherapeutics Inc (1996–2024)
Year-by-year earnings quality comparison for Protalix Biotherapeutics Inc. For live market cap and the full company financial profile, see Protalix Biotherapeutics Inc market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.96x | $8.67 Million | $2.93 Million | ▲ +1965.7% |
| 2023 | -0.16x | $-1.32 Million | $8.31 Million | ▲ +92.4% |
| 1997 | -2.09x | $-247.92K | $118.44K | ▼ -579.4% |
| 1996 | -0.31x | $-40.57K | $131.68K | — |